The investment firm Starboard Value acquired a $1bn stake in Pfizer Inc. with a goal of turning the company around, but whether an activist investor can pivot the big pharma onto a growth trajectory remains to be seen.
An Activist Investor Makes A Play For Pfizer
Starboard Value has reportedly bought a $1bn stake in Pfizer with an ambition to turn the big pharma around. But growth, not cost cuts, are Pfizer’s challenge.
